Christopher Graber

Christopher Graber

@idsensei.bsky.social

ID doc, steward, dad, fellowship program director

1,831 Followers 120 Following 102 Posts Joined Dec 2023
1 day ago
Preview
Airtable | Everyone's app platform Airtable is a low-code platform for building collaborative apps. Customize your workflow, collaborate, and achieve ambitious outcomes. Get started for free.

does this work?

airtable.com/appzPcoBRgsm...

0 0 1 0
1 day ago

priority list signup for non-US physicians and non-physician folks in healthcare: airtable.com/appzPcoBRgsmUX…

0 0 1 0
1 day ago

what I like about Roon so far:
1. More back-and-forth discussion
2. Ability to follow certain topics in “spaces” (e.g., AI in medicine, health policy, med ed, medical reasoning)
3. You can’t tell how many followers you have (less clout-chasing and virtue signaling)
4. No bots or trolls

2 0 0 0
1 day ago

100% biggest limitation right now. Hopefully temporary (remember when Bluesky was invite-only?)

0 0 0 0
1 day ago

So far it’s limited to US-based physicians (need NPI) but goal is to add others (need our ID pharmacists and international colleagues!) over time

0 0 1 0
1 day ago
Preview
Roon for Medical Experts Where the world’s best physicians share knowledge and advance medicine—together.

Join here!

www.roon.com?utm_campaign...

0 0 1 0
1 day ago
Post image

Remember the glory days of #IDTwitter? Want to have discussions with your colleagues without sifting through the slop of X and the echo chambers of Bluesky? Come join what we are building over at Roon!

1 0 2 0
3 weeks ago

Bruin. Doin’ us proud.

0 0 0 0
3 weeks ago
Preview
USAJOBS connects job seekers with federal jobs across the United States and around the world as the official employment site for the federal government The Clinical Pharmacist Specialist for Infectious Diseases must be a licensed pharmacist, have expert knowledge of infectious disease/antimicrobial medication therapy and management, and have an exper...

Are you an ID pharmacist currently in the VA system who wants to live in an awesome city and work with awesome people?

Look no further.

www.usajobs.gov/job/858066800

0 0 0 0
3 weeks ago
Preview
Antibiotics in community-acquired pneumonia when respiratory viruses are detected: Adding more fuel to the fire? A study in CID examined associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays.

My latest for IDSA Journal Club: a review of a recent CID paper that finds similar outcomes in CAP patients with pos viral testing when treated with 0-2d vs 5-7d abx, adding fuel to recent IDSA-ATS controversy.

www.idsociety.org/science-spea...

1 0 0 0
1 month ago

just referred to a smoldering leukocytosis as “low-key” on rounds today…not sure if I’m chopped, cringe, or goated

2 0 2 0
2 months ago
Validate User

I did not have @mmpharmd.bsky.social making a 6-7 reference in a CID article on my bingo card of things that were going to make my day today but here we are

academic.oup.com/cid/advance-...

4 1 1 0
2 months ago

did ABIM really just send me my LKA Wrapped?

0 0 0 0
2 months ago
Preview
Anti-staphylococcal penicillins versus cefazolin for methicillin-susceptible S. aureus bacteremia: Is there a role for determining blaZ type? A study in The Lancet addressed cloxacillin versus cefazolin for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber.

we’re talkin’ CloCeBa at @idsainfo.bsky.social Journal Club this month! Do we need to think about adding blaZ type to rapid diagnostic panels for MSSA bacteremia?

www.idsociety.org/science-spea...

1 1 0 0
3 months ago
Preview
Restoring Confidence in Public Health | NEJM A confluence of interrelated factors has put past progress in public health at serious risk in the United States. How did we get here, and what can public health professionals do about it?

The 6 “coms” of why we are losing the battle over public health: complacency, commitment, commercialism, complexity, communication, and comportment

www.nejm.org/doi/full/10....

2 0 0 0
4 months ago
Preview
Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship This white paper, devised from the Infectious Diseases Society of America's National Training Program Director annual meeting, outlines practical strategie

With UW’s Dr Paul Pottinger and others, new discussion re: fostering ID advocacy in ID fellowship.

They note:
Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy

academic.oup.com/ofid/advance... #IDSky

4 3 0 0
4 months ago

5. The Learner (redux): the late career person who no longer has to play hard at the game and is at the meeting for the science and to have awesome dinners with friends.

Making it to this stage is the aspirational goal.

0 0 0 0
4 months ago

4. The Leader: the mid to late career person who mostly goes to meet with other key Leaders to plan grants, policies, and initiatives. Only catches a few educational sessions. Comes late and leaves early.

0 0 1 0
4 months ago

3. The Organizer: the midcareer person involved in planning sessions, moderating, leading symposia, getting people to meet who need to meet. Lucky to make it to half the educational stuff they aren’t involved in.

0 0 1 0
4 months ago

2. The Presenter: the trainee or early career person who has a poster or oral presentation, still learns and absorbs most of the meeting, but the presentation is the focus.

0 0 1 0
4 months ago

beginning to realize the stages of @idweek.bsky.social attendance according to career stage:

1. The Learner: the student/resident/fellow that goes to learn and absorb.

2 0 1 0
4 months ago

the day that AI can do schedule-making better than me is the day my work is done as a PD…it’s gonna be a while

1 0 1 0
4 months ago
Preview
Transplant Infectious Diseases Career Development Position 2026-2027 University of California, Los Angeles is hiring. Apply now!

Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380

8 7 1 1
4 months ago

Well done to all the teams! Time for everyone to start making plans for BugBowl 2026 in DC!

1 0 0 0
4 months ago

Get psyched! Come for the ATL-themed puns, stay for the knowledge!

2 1 0 0
4 months ago
Preview
DOT-ting i's and crossing t's: More evidence for using long-acting glycopeptides to finish therapy of complicated S. aureus bacteremia A JAMA study looked at dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. Read IDSA's Journal Club review.

On IDSA’s & HIVMA’s Science Speaks blog: Christopher J. Graber, MD, MPH, FIDSA, explores dalbavancin versus standard therapy for completion of treatment of complicated S. aureus bacteremia. https://bit.ly/4ncqnAt

6 2 0 1
5 months ago
Post image
1 0 0 0
5 months ago
Post image

Looking to do some stewardship and/or hospital epi? Join me, @wbranchelliman.bsky.social, and our crew at VA Greater Los Angeles!

5 1 1 0
5 months ago

best admin assistant (and pre-interview Zoom DJ) ever!

3 0 0 0
6 months ago

Colleagues- in case this was missed during summer vacation, please share. I just went to the Bowl again last week and saw Yo-Yo Ma and Angelique Kidjo. The Bowl is not the only reason to be in LA....but it is pretty spectacular. Also my ASP team is just the bee's knees.

2 1 0 0